Siddhartha Jain

Latest from Siddhartha Jain

stacked hands on virtual globe
Information Technology
Transforming Biopharmaceutical Research Embracing the Potential of Digital Collaboration PlatformsTransforming Biopharmaceutical Research Embracing the Potential of Digital Collaboration Platforms
byNarendra Sharma, Siddhartha Jain
Jun 12, 2024
Achieving Competitive Advantage in the Biopharmaceutical Industry
Risk Management
Achieving Competitive Advantage in the Biopharmaceutical IndustryAchieving Competitive Advantage in the Biopharmaceutical Industry
bySiddhartha Jain
Apr 12, 2016

All from Siddhartha Jain

When Is a Virtual Business Model Suitable for Biopharmaceutical Companies?
Economics
When Is a Virtual Business Model Suitable for Biopharmaceutical Companies?
When Is a Virtual Business Model Suitable for Biopharmaceutical Companies?
Apr 14, 2015
bySiddhartha Jain
A Case for Biopharmaceutical Operations in Low-Cost Countries to Maximize Return on Investment
Business
A Case for Biopharmaceutical Operations in Low-Cost Countries to Maximize Return on Investment
A Case for Biopharmaceutical Operations in Low-Cost Countries to Maximize Return on Investment
Feb 6, 2015
bySiddhartha Jain
Revenue per FTE and Cost per FTE: Metrics of Operational Efficiency and Performance
Economics
Revenue per FTE and Cost per FTE: Metrics of Operational Efficiency and Performance
Revenue per FTE and Cost per FTE: Metrics of Operational Efficiency and Performance
Dec 11, 2014
bySiddhartha Jain
Process Effectiveness Analysis Toward Enhanced Operational Efficiency, Faster Product Development, and Lower Operating Costs
Economics
Process Effectiveness Analysis Toward Enhanced Operational Efficiency, Faster Product Development, and Lower Operating Costs
Process Effectiveness Analysis Toward Enhanced Operational Efficiency, Faster Product Development, and Lower Operating Costs
Nov 10, 2014
bySiddhartha Jain
Due Diligence of Early Stage Technologies: Achieving Rapid Product Development with Low R&D Costs
Biosimilars
Due Diligence of Early Stage Technologies: Achieving Rapid Product Development with Low R&D Costs
Due Diligence of Early Stage Technologies: Achieving Rapid Product Development with Low R&D Costs
Jun 1, 2014
bySiddhartha Jain

Webinars

ask the expert webcast
ATE Webcasts
More Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process IntensificationMore Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process Intensification
scientist at OPUS 80R
Sponsored Content
Reduce Risk and Enable Continuous Manufacturing Using Pre-Packed Columns for Multicolumn ChromatographyReduce Risk and Enable Continuous Manufacturing Using Pre-Packed Columns for Multicolumn Chromatography
Resilience logo
Sponsored Content
Built to Serve Innovation: A Briefing on Commercial Readiness at ResilienceBuilt to Serve Innovation: A Briefing on Commercial Readiness at Resilience
Insider News
See all
Sep 23 - Sep 26, 2024
Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Learn More

Innovative Technology

Lonza Fab Vial Hands
Sponsored Content
A Comprehensive and Flexible Approach to CMC for Fab and Fc-Fusion Development ProgramsA Comprehensive and Flexible Approach to CMC for Fab and Fc-Fusion Development Programs
byBPI Contributor
Jul 15, 2024
1 Min Read
Emerson Practical Guide
Sponsored Content
A Practical Guide to Optimizing Your Drug Manufacturing Process in Increasingly Demanding EnvironmentsA Practical Guide to Optimizing Your Drug Manufacturing Process in Increasingly Demanding Environments
byBPI Contributor
Jul 3, 2024
1 Min Read
Gibco CHO Playbook
Sponsored Content
CHO Playbook Gibco™ CHO Cell Culture Solutions for BiomanufacturingCHO Playbook Gibco™ CHO Cell Culture Solutions for Biomanufacturing
byBPI Contributor
Jun 7, 2024
1 Min Read